For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
6
views
0
references
 Top references
cited by
0
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      1,753
      similar
       All similar
      • Record: found
      • Abstract: not found
      • Article: not found

      Cost-Effectiveness of Crizotinib, Ceritinib, and Alectinib as First-Line Treatments for Anaplastic Lymphoma Kinase-Positive (ALK+) Metastatic Non-Small Cell Lung Cancer

      Author(s): ,
      Publication date Created:
      Publication date (Print):
      Journal: Value in Health
      Publisher: Elsevier BV

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          Title: Value in Health
          Abbreviated Title: Value in Health
          Publisher: Elsevier BV
          ISSN (Print): 10983015
          Publication date Created: May 2018
          Publication date (Print): May 2018
          Volume: 21
          Pages: S32-S33
          Article
          DOI: 10.1016/j.jval.2018.04.208
          SO-VID: f405981e-16f5-4b5d-885c-2747aaeb98c5
          Copyright © © 2018
          License:

          https://www.elsevier.com/tdm/userlicense/1.0/

          History

          Data availability:

          Comments

          Comment on this article